Accelerating Systematic Literature Reviews: How AI is redefining Evidence-Based Medicine

Systematic Literature Reviews (SLRs) remain the gold standard for evidence-based medicine. However, the traditional process faces a significant hurdle: the manual screening of thousands of abstracts. This phase is notoriously slow, resource-heavy, and susceptible to human fatigue, creating a bottleneck in the delivery of critical clinical insights.

At Quinten Health, we have developed and validated a semi-automated, AI-powered solution designed to accelerate the screening process without compromising the scientific rigor required by the industry.

The Innovation: LLMs Meets Literature Intelligence

By leveraging Large Language Models (LLMs) and advanced Literature Intelligence, our tool functions as a “first-pass” expert to streamline the workflow:

• Search Integration: Researchers input their standard database queries (e.g., PubMed) as they normally would.
• Natural Language Criteria: Selection criteria for abstract screening are entered in plain language, no complex coding required.
• Automated Justification: The AI analyzes titles and abstracts, providing a YES, NO, or UNCERTAIN status for each document, backed by a clear rationale for every criterion.
• Smart Shortlisting: Human reviewers can then focus their expertise exclusively on a refined shortlist, drastically reducing the manual labor involved in the initial “noise” reduction.

Proven Impact: By the Numbers

Our approach isn’t just theoretical. During a validation study across five expert-led literature reviews, the results were transformative:

Metric	Outcome
Workload Reduction	Manual abstract screening was reduced by 46% to 91%.
Sensitivity/Accuracy	Over 96% of articles identified by human experts were captured in the AI shortlists.
Case Study	A pool of 203 publications narrowed to 24 abstracts, resulting in 9 high-value inclusions.

The Strategic Advantage

By automating the exclusion of irrelevant data, we enable researchers to broaden the scope of their reviews without extending their timelines. The ultimate benefit is clear: faster access to comprehensive, high-quality evidence to support clinical decision-making.